Overview
Clinical innovation encompasses the designing and delivering of new and impactful healthcare products and solutions. These often start from a healthcare provider’s ideas which are translated into a viable product or technology.
SPRING Singapore (now known as Enterprise Singapore) and Tan Tock Seng Hospital signed a memorandum of understanding on 27 June 2012 to collaboratively facilitate innovation projects between TTSH clinicians and Singapore medical technology and biomedical companies.
SPRING Singapore and TTSH jointly established the Co-innovation Programme Office (CPO) to catalyse the formation of partnerships between clinicians and Singapore medical technology companies to co-develop innovative healthcare technologies. The CPO, staffed by representatives from SPRING Singapore and TTSH’s CRIO, facilitates the translating of ideas into feasible products or services that can improve patient care and command high commercial value.
The CRIO Clinical Innovation team’s role includes the following:
- Bridge the gap between clinicians’ ideas and technology development
- Advise on funding streams for projects
- Facilitate partnerships between clinicians and Singapore medical technology companies
- Co-develop innovative healthcare products and solutions that are clinically impactful and that meet the needs of end-users world-wide through commercialisation